A double-blind placebo-controlled cross over trial of bupropion in smoking reduction in schizophrenia
- 15 July 2005
- journal article
- other
- Published by Elsevier in Schizophrenia Research
- Vol. 76 (2-3) , 353-356
- https://doi.org/10.1016/j.schres.2005.02.021
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- RELATIONSHIP BETWEEN TOBACCO SMOKING AND POSITIVE AND NEGATIVE SYMPTOMS IN SCHIZOPHRENIAJournal of Nervous & Mental Disease, 2002
- A placebo controlled trial of bupropion for smoking cessation in schizophreniaBiological Psychiatry, 2002
- A pilot trial of bupropion added to cognitive behavioral therapy for smoking cessation in schizophreniaNicotine & Tobacco Research, 2001
- Effects of Sustained-Release Bupropion and Supportive Group Therapy on Cigarette Consumption in Patients With SchizophreniaAmerican Journal of Psychiatry, 2001
- A Controlled Trial of Sustained-Release Bupropion, a Nicotine Patch, or Both for Smoking CessationNew England Journal of Medicine, 1999
- Efficacy of bupropion for smoking cessation in smokers with a former history of major depression or alcoholism∗The British Journal of Psychiatry, 1999
- Nicotine Dependence in Schizophrenia: Clinical Phenomena and Laboratory FindingsAmerican Journal of Psychiatry, 1998
- Schizophrenia and Substance AbusePsychiatric Annals, 1996